Local Institution - 0046 — Homewood, Alabama

Local Institution - 0046 is a clinical research site located in Homewood, Alabama, United States 35209.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 0046 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Agitation, Alzheimer Disease.

Sponsors: Celgene.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Homewood

Browse all research sites in Alabama · View every site in Homewood

• University of Alabama at Birmingham 1
• Urology Centers of Alabama
• Alabama Neurology Associates
• Research Site
• Urology Centers Of Alabama Pc
• GSK Investigational Site
• Pfizer Investigational Site
• Central Alabama Research
• Novartis Investigative Site
• Urology Center of Alabama
• Warner Chilcott Investigational Site
• Local Institution - 1029

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0046?

Local Institution - 0046 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0046 conducted?

Local Institution - 0046 has 1 clinical trials on record, with 1 currently active. Their work covers Agitation, Alzheimer Disease.

Is Local Institution - 0046 accredited by Crixeo Clinical Trials?

Local Institution - 0046 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 0046?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.